{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:17:13Z","timestamp":1791256633272,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004847","name":"Zahedan University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.ZAUMS.REC.1399.197"],"award-info":[{"award-number":["IR.ZAUMS.REC.1399.197"]}],"id":[{"id":"10.13039\/501100004847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10787-022-01029-4","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T10:08:06Z","timestamp":1657793286000},"page":"1645-1657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients"],"prefix":"10.1007","volume":"30","author":[{"given":"Habib","family":"Ghaznavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Mohammadghasemipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Shirvaliloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Kazem","family":"Momeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Metanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Gorgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Abedipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Sartipi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Reza Salimi","family":"Khorashad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omolbanin","family":"Shahraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadese","family":"Ataee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7996-845X","authenticated-orcid":false,"given":"Roghayeh","family":"Sheervalilou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Sargazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"issue":"25","key":"1029_CR1","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.2174\/1381612826666200904171940","volume":"27","author":"M Abualhasan","year":"2021","unstructured":"Abualhasan M, Zatar N, Shehab KA, Shraim N (2021) Tablet formulation of a synthesized celecoxib potassium salt and development of a validated method for its analysis. Curr Pharm Des 27(25):2872\u20132880","journal-title":"Curr Pharm Des"},{"issue":"18","key":"1029_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025013","volume":"100","author":"K Al Saleh","year":"2021","unstructured":"Al Saleh K, AlQahtani RM (2021) Platelet count patterns and patient outcomes in sepsis at a tertiary care center: beyond the APACHE score. Medicine 100(18):e25013","journal-title":"Medicine"},{"issue":"2","key":"1029_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3390\/covid1020042","volume":"1","author":"HK Al-Hakeim","year":"2021","unstructured":"Al-Hakeim HK, Al-Hamami SA, Almulla AF, Maes M (2021) Increased serum thromboxane A2 and prostacyclin but lower complement C3 and C4 levels in COVID-19: associations with chest CT scan anomalies and lowered peripheral oxygen saturation. COVID 1(2):489\u2013502","journal-title":"COVID"},{"issue":"8","key":"1029_CR4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/135965350601100803","volume":"11","author":"C Amici","year":"2006","unstructured":"Amici C, Caro AD, Ciucci A, Chiappa L, Castilletti C, Martella V et al (2006) Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther 11(8):1021\u20131030","journal-title":"Antivir Ther"},{"issue":"21","key":"1029_CR5","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1001\/jama.2018.6360","volume":"319","author":"K Broglio","year":"2018","unstructured":"Broglio K (2018) Randomization in clinical trials: permuted blocks and stratification. JAMA 319(21):2223\u20132224","journal-title":"JAMA"},{"issue":"3","key":"1029_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0002-9343(00)00683-5","volume":"110","author":"F Catella-Lawson","year":"2001","unstructured":"Catella-Lawson F, Crofford LJ (2001) Cyclooxygenase inhibition and thrombogenicity. Am J Med 110(3):28\u201332","journal-title":"Am J Med"},{"issue":"4","key":"1029_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1053\/j.gastro.2004.07.010","volume":"127","author":"FK Chan","year":"2004","unstructured":"Chan FK, Hung LC, Suen BY, Wong VW, Hui AJ, Wu JC et al (2004) Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. Gastroenterology 127(4):1038\u20131043","journal-title":"Gastroenterology"},{"issue":"5","key":"1029_CR8","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.3390\/v7052268","volume":"7","author":"J Chen","year":"2015","unstructured":"Chen J, Jiang L, Lan K, Chen X (2015) Celecoxib inhibits the lytic activation of Kaposi\u2019s sarcoma-associated herpesvirus through down-regulation of RTA expression by inhibiting the activation of p38 MAPK. Viruses 7(5):2268\u20132287","journal-title":"Viruses"},{"key":"1029_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.781352","volume":"12","author":"C Cioccarelli","year":"2021","unstructured":"Cioccarelli C, Angioni R, Venegas FC, Bertoldi N, Munari F, Cattelan A et al (2021) IL1\u03b2 promotes TMPRSS2 expression and SARS-CoV-2 cell entry through the p38 MAPK-GATA2 axis. Front Immunol 12:781352. https:\/\/doi.org\/10.3389\/fimmu.2021.781352","journal-title":"Front Immunol"},{"issue":"3","key":"1029_CR10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/ijms23031049","volume":"23","author":"N de Bruin","year":"2022","unstructured":"de Bruin N, Schneider A-K, Reus P, Talmon S, Ciesek S, Bojkova D et al (2022) Ibuprofen, flurbiprofen, etoricoxib or paracetamol do not influence ACE2 expression and activity in vitro or in mice and do not exacerbate in-vitro SARS-CoV-2 infection. Int J Mol Sci 23(3):1049","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1029_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/neu.2020.7332","volume":"38","author":"ST DeKosky","year":"2021","unstructured":"DeKosky ST, Kochanek PM, Valadka AB, Clark RS, Chou SH-Y, Au AK et al (2021) Blood biomarkers for detection of brain injury in COVID-19 patients. J Neurotrauma 38(1):1\u201343","journal-title":"J Neurotrauma"},{"issue":"2","key":"1029_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/00000542-200502000-00026","volume":"102","author":"G Dembo","year":"2005","unstructured":"Dembo G, Park SB, Kharasch ED (2005) Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans. J Am Soc Anesthesiol 102(2):409\u2013415","journal-title":"J Am Soc Anesthesiol"},{"issue":"1","key":"1029_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-31569-1","volume":"8","author":"LC Dutton","year":"2018","unstructured":"Dutton LC, Dudhia J, Catchpole B, Hodgkiss-Geere H, Werling D, Connolly DJ (2018) Cardiosphere-derived cells suppress allogeneic lymphocytes by production of PGE2 acting via the EP4 receptor. Sci Rep 8(1):1\u201314","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"1029_CR14","first-page":"531","volume":"11","author":"M Eslamijouybari","year":"2020","unstructured":"Eslamijouybari M, Heydari K, Maleki I, Moosazadeh M, Hedayatizadeh-Omran A, Vahedi L et al (2020) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19 patients and control group and relationship with disease prognosis. Caspian J Intern Med 11(Suppl 1):531","journal-title":"Caspian J Intern Med"},{"key":"1029_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fmed.2020.00301","volume":"7","author":"X Feng","year":"2020","unstructured":"Feng X, Li S, Sun Q, Zhu J, Chen B, Xiong M, Cao G (2020) Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis. Front Med 7:301","journal-title":"Front Med"},{"issue":"7","key":"1029_CR16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/cbin.11800","volume":"46","author":"H Ghaznavi","year":"2022","unstructured":"Ghaznavi H, Shirvaliloo M, Sargazi S, Mohammadghasemipour Z, Shams Z, Hesari Z et al (2022) SARS-CoV-2 and influenza viruses: strategies to cope with coinfection and bioinformatics perspective. Cell Biol Int 46(7):1009\u20131020. https:\/\/doi.org\/10.1002\/cbin.11800","journal-title":"Cell Biol Int"},{"issue":"11","key":"1029_CR17","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.3390\/ijms21113793","volume":"21","author":"A Gimeno","year":"2020","unstructured":"Gimeno A, Mestres-Truyol J, Ojeda-Montes MJ, Macip G, Saldivar-Espinoza B, Cereto-Massagu\u00e9 A et al (2020) Prediction of novel inhibitors of the main protease (M-pro) of SARS-CoV-2 through consensus docking and drug reposition. Int J Mol Sci 21(11):3793","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1029_CR18","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1249\/MSS.0000000000001657","volume":"50","author":"H Grimm","year":"2018","unstructured":"Grimm H, Kretzschmar J, Cook MD, Brown MD (2018) The effects of exercise, aspirin, and celecoxib in an atherogenic environment. Med Sci Sports Exerc 50(10):2033\u20132039","journal-title":"Med Sci Sports Exerc"},{"key":"1029_CR19","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/jmv.27477","volume":"94","author":"M Heidari Nia","year":"2021","unstructured":"Heidari Nia M, Rokni M, Mirinejad S, Kargar M, Rahdar S, Sargazi S et al (2021) Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: a case\u2013control study and in silico analyses. J Med Virol 94:1502\u20131512","journal-title":"J Med Virol"},{"key":"1029_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.561674","author":"W Hong","year":"2020","unstructured":"Hong W, Chen Y, You K, Tan S, Wu F, Tao J et al (2020) Celebrex adjuvant therapy on coronavirus disease 2019: an experimental study. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.561674","journal-title":"Front Pharmacol"},{"issue":"6","key":"1029_CR21","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.3390\/ijms22063092","volume":"22","author":"SM Hosseinikhah","year":"2021","unstructured":"Hosseinikhah SM, Barani M, Rahdar A, Madry H, Arshad R, Mohammadzadeh V, Cucchiarini M (2021) Nanomaterials for the diagnosis and treatment of inflammatory arthritis. Int J Mol Sci 22(6):3092","journal-title":"Int J Mol Sci"},{"key":"1029_CR22","doi-asserted-by":"crossref","unstructured":"Khupse R, Dixit P (2020) Potential antiviral mechanism of hydroxychloroquine in COVID-19 and further extrapolation to celecoxib (Celebrex) for future clinical trials. Available at SSRN 3570102","DOI":"10.2139\/ssrn.3570102"},{"issue":"11","key":"1029_CR23","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.4049\/jimmunol.1700503","volume":"201","author":"N Kim","year":"2018","unstructured":"Kim N, Lannan KL, Thatcher TH, Pollock SJ, Woeller CF, Phipps RP (2018) Lipoxin B4 enhances human memory B cell antibody production via upregulating cyclooxygenase-2 expression. J Immunol 201(11):3343\u20133351","journal-title":"J Immunol"},{"issue":"4473","key":"1029_CR24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1126\/science.6254151","volume":"210","author":"FA Kuehl Jr","year":"1980","unstructured":"Kuehl FA Jr, Egan RW (1980) Prostaglandins, arachidonic acid, and inflammation. Science 210(4473):978\u2013984","journal-title":"Science"},{"key":"1029_CR25","doi-asserted-by":"crossref","unstructured":"Kwong K, Kollarik M, Nassenstein C, Ru F, Undem BJ (2008) P2X2 receptors differentiate placodal vs. neural crest C-fiber phenotypes innervating guinea pig lungs and esophagus. Am J Physiol-Lung Cell Mol Physiol 295(5): L858-L865","DOI":"10.1152\/ajplung.90360.2008"},{"issue":"4","key":"1029_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1086\/590499","volume":"198","author":"SM Lee","year":"2008","unstructured":"Lee SM, Cheung C-Y, Nicholls JM, Hui KP, Leung CY, Uiprasertkul M et al (2008) Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis 198(4):525\u2013535","journal-title":"J Infect Dis"},{"issue":"7","key":"1029_CR27","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1096\/fj.06-6589com","volume":"21","author":"M Liu","year":"2007","unstructured":"Liu M, Yang Y, Gu C, Yue Y, Wu KK, Wu J, Zhu Y (2007) Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via both calcium-dependent and calcium-independent protein kinase C pathways. FASEB J 21(7):1586\u20131596","journal-title":"FASEB J"},{"key":"1029_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cca.2020.04.034","volume":"508","author":"G Lu","year":"2020","unstructured":"Lu G, Wang J (2020) Dynamic changes in routine blood parameters of a severe COVID-19 case. Clin Chim Acta 508:98\u2013102","journal-title":"Clin Chim Acta"},{"issue":"11","key":"1029_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204746","volume":"13","author":"GM Masclee","year":"2018","unstructured":"Masclee GM, Straatman H, Arf\u00e8 A, Castellsague J, Garbe E, Herings R et al (2018) Risk of acute myocardial infarction during use of individual NSAIDs: a nested case-control study from the SOS project. PLoS ONE 13(11):e0204746","journal-title":"PLoS ONE"},{"issue":"3","key":"1029_CR30","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.4049\/jimmunol.1300290","volume":"192","author":"K Morimoto","year":"2014","unstructured":"Morimoto K, Shirata N, Taketomi Y, Tsuchiya S, Segi-Nishida E, Inazumi T et al (2014) Prostaglandin E2\u2013EP3 signaling induces inflammatory swelling by mast cell activation. J Immunol 192(3):1130\u20131137","journal-title":"J Immunol"},{"key":"1029_CR31","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen SE, Yeomans ND, Solomon DH, L\u00fcscher TF, Libby P, Husni ME et al (2016) Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 375:2519\u20132529","journal-title":"N Engl J Med"},{"issue":"2","key":"1029_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.clim.2009.04.012","volume":"132","author":"H Niwa","year":"2009","unstructured":"Niwa H, Satoh T, Matsushima Y, Hosoya K, Saeki K, Niki T et al (2009) Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1-and\/or Th17-mediated skin inflammation. Clin Immunol 132(2):184\u2013194","journal-title":"Clin Immunol"},{"key":"1029_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198202","volume":"291","author":"JC Pieretti","year":"2021","unstructured":"Pieretti JC, Rubilar O, Weller RB, Tortella GR, Seabra AB (2021) Nitric oxide (NO) and nanoparticles\u2013potential small tools for the war against COVID-19 and other human coronavirus infections. Virus Res 291:198202","journal-title":"Virus Res"},{"issue":"1","key":"1029_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-4-55","volume":"4","author":"M Raaben","year":"2007","unstructured":"Raaben M, Einerhand AW, Taminiau LJ, Van Houdt M, Bouma J, Raatgeep RH et al (2007) Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection. Virol J 4(1):1\u20135","journal-title":"Virol J"},{"issue":"21","key":"1029_CR35","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1111\/bph.15206","volume":"177","author":"CT Robb","year":"2020","unstructured":"Robb CT, Goepp M, Rossi AG, Yao C (2020) Non-steroidal antiinflammatory drugs, prostaglandins, and COVID-19. Br J Pharmacol 177(21):4899\u20134920","journal-title":"Br J Pharmacol"},{"issue":"15","key":"1029_CR36","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2174\/1381612823666170317165350","volume":"24","author":"CA Rojas-Carranza","year":"2018","unstructured":"Rojas-Carranza CA, Bustos-Cruz RH, Pino-Pinz\u00f3n CJ, Ariza-Marquez YV, G\u00f3mez-Bello RM, Canadas-Garre M (2018) Diabetes-related neurological implications and pharmacogenomics. Curr Pharm Des 24(15):1695\u20131710","journal-title":"Curr Pharm Des"},{"issue":"4","key":"1029_CR37","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1476-5381.2012.02189.x","volume":"168","author":"J S\u00e4fholm","year":"2013","unstructured":"S\u00e4fholm J, Dahl\u00e9n SE, Delin I, Maxey K, Stark K, Cardell LO, Adner M (2013) PG E2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors. Br J Pharmacol 168(4):794\u2013806","journal-title":"Br J Pharmacol"},{"issue":"15","key":"1029_CR38","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1073\/pnas.90.15.7240","volume":"90","author":"D Salvemini","year":"1993","unstructured":"Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci 90(15):7240\u20137244","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"1029_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","volume":"15","author":"J Sharma","year":"2007","unstructured":"Sharma J, Al-Omran A, Parvathy S (2007) Role of nitric oxide in inflammatory diseases. Inflammopharmacology 15(6):252\u2013259","journal-title":"Inflammopharmacology"},{"issue":"7","key":"1029_CR40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MPH.0000000000002264","volume":"43","author":"S Singh","year":"2021","unstructured":"Singh S, Sharma R, Singh J, Jain K, Paul D (2021) Thrombocytopenia in COVID-19: focused summary of current understanding of mechanisms and clinical implications. J Pediatr Hematol Oncol 43(7):243\u2013248","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"1029_CR41","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/nano10050852","volume":"10","author":"VS Sivasankarapillai","year":"2020","unstructured":"Sivasankarapillai VS, Pillai AM, Rahdar A, Sobha AP, Das SS, Mitropoulos AC et al (2020) On facing the SARS-CoV-2 (COVID-19) with combination of nanomaterials and medicine: possible strategies and first challenges. Nanomaterials 10(5):852","journal-title":"Nanomaterials"},{"key":"1029_CR42","doi-asserted-by":"publisher","unstructured":"Smeitink J, Jiang X, Pecheritsyna S, Renkema H, van Maanen R, Beyrath J (2020) Hypothesis: mPGES-1-derived prostaglandin E2, a so far missing link in COVID-19 pathophysiology? https:\/\/doi.org\/10.20944\/preprints202004.0180.v1","DOI":"10.20944\/preprints202004.0180.v1"},{"issue":"9","key":"1029_CR43","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.3390\/molecules26092593","volume":"26","author":"O Terrier","year":"2021","unstructured":"Terrier O, Dilly S, Pizzorno A, Chalupska D, Humpolickova J, Bou\u0159a E et al (2021) Antiviral properties of the NSAID drug naproxen targeting the nucleoprotein of SARS-CoV-2 coronavirus. Molecules 26(9):2593","journal-title":"Molecules"},{"issue":"9","key":"1029_CR44","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1023\/A:1018846912032","volume":"43","author":"H Ukawa","year":"1998","unstructured":"Ukawa H, Yamakuni H, Kato S, Takeuchi K (1998) Effects of cyclooxygenase-2 selective and nitric oxide-releasing non-steroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Dig Dis Sci 43(9):2003\u20132011","journal-title":"Dig Dis Sci"},{"issue":"8","key":"1029_CR45","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.biocel.2006.02.003","volume":"38","author":"X Yan","year":"2006","unstructured":"Yan X, Hao Q, Mu Y, Timani KA, Ye L, Zhu Y, Wu J (2006) Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT\/enhancer binding protein. Int J Biochem Cell Biol 38(8):1417\u20131428","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"1029_CR46","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1152\/jappl.1993.74.1.224","volume":"74","author":"CA Zamora","year":"1993","unstructured":"Zamora CA, Baron DA, Heffner JE (1993) Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury. J Appl Physiol 74(1):224\u2013229","journal-title":"J Appl Physiol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01029-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-01029-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01029-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T15:21:56Z","timestamp":1700839316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-01029-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-01029-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare that they have conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors are agreed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Webpage of ethical approval code is available at.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}